These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent. Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134 [TBL] [Abstract][Full Text] [Related]
5. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)]. Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223 [No Abstract] [Full Text] [Related]
6. [The role of adrenal gland x-ray computed tomography and scintigraphy using radiolabelled norcholesterol in the etiological diagnosis of primary hyperaldosteronism]. Abram M; Peltier P; Murat A; Chupin M; Dupas B; Gaillard F; Chatal JF; Charbonnel B Rev Med Interne; 1993; 14(7):691-7. PubMed ID: 8191071 [TBL] [Abstract][Full Text] [Related]
7. The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism. Gross MD; Shapiro B; Grekin RJ; Meyers L; Swanson DP; Beierwaltes WH J Clin Endocrinol Metab; 1983 Sep; 57(3):477-81. PubMed ID: 6874887 [TBL] [Abstract][Full Text] [Related]
11. Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia. Fischer M; Vetter W; Winterg B; Zidek W; Vetter H Eur J Nucl Med; 1982; 7(5):222-4. PubMed ID: 7094925 [TBL] [Abstract][Full Text] [Related]